Tucker Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Tucker Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$12.7M	Sell	1,011,064 -100,000	-9%	-$1.14M	3.71%	6
2025 Q3	$11.1M	Hold	1,111,064	–	–	3.35%	7
2025 Q2	$8.99M	Hold	1,111,064	–	–	2.87%	7
2025 Q1	$9.31M	Hold	1,111,064	–	–	3.02%	7
2024 Q4	$8.8M	Hold	1,111,064	–	–	0.94%	11
2024 Q3	$9.24M	Hold	1,111,064	–	–	2.13%	11
2024 Q2	$7.06M	Buy	+1,111,064	New	+$7.05M	1.54%	14

Other funds holding AMRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Tucker Asset Management's AMRX Position: Q4 2025 in Review

Tucker Asset Management reduced its Amneal Pharmaceuticals (AMRX) stake by 9% in Q4 2025, selling an estimated $1.14M and leaving 1,011,064 shares worth $12.7M. The position accounts for 3.71% of the portfolio, ranked #6.

Tucker Asset Management first reported a position in AMRX in Q2 2024 and has held it in 7 quarters since. 277 funds tracked by Wall St. Rank hold AMRX as of Q4 2025.

Tucker Asset Management held 1,011,064 shares of Amneal Pharmaceuticals worth $12.7M as of Q4 2025.
Tucker Asset Management sold 100,000 Amneal Pharmaceuticals shares in Q4 2025, an estimated $1.14M.
Amneal Pharmaceuticals made up 3.71% of Tucker Asset Management's portfolio in Q4 2025, its #6 holding.
Tucker Asset Management first reported a position in Amneal Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
277 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2025.

Based on Tucker Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.